Skip to main content
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
47.75
-0.15 (-0.31%)
Dec 5, 2025, 1:02 PM CST

G&E Herbal Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3,0433,3393,4402,9721,5581,940
Upgrade
Market Cap Growth
-9.05%-2.92%15.73%90.71%-19.66%-3.19%
Upgrade
Enterprise Value
2,6323,0173,2262,8491,4461,819
Upgrade
Last Close Price
47.7551.6552.6745.5123.8629.70
Upgrade
PE Ratio
21.3032.7247.51402.69--
Upgrade
PS Ratio
9.7613.4118.9646.0163.4368.71
Upgrade
PB Ratio
3.384.014.514.302.282.76
Upgrade
P/TBV Ratio
3.964.775.475.342.843.42
Upgrade
P/FCF Ratio
18.3725.9431.8630.64--
Upgrade
P/OCF Ratio
17.9124.8030.3129.73-2515.89
Upgrade
EV/Sales Ratio
8.4412.1217.7844.1058.8364.44
Upgrade
EV/EBITDA Ratio
15.6623.3535.88191.43--
Upgrade
EV/EBIT Ratio
16.7025.2239.98519.39--
Upgrade
EV/FCF Ratio
15.8923.4429.8829.37--
Upgrade
Debt / Equity Ratio
0.000.000.00---
Upgrade
Debt / EBITDA Ratio
0.010.010.02---
Upgrade
Debt / FCF Ratio
0.010.010.02---
Upgrade
Asset Turnover
-0.270.220.090.040.04
Upgrade
Inventory Turnover
-1.961.551.140.811.07
Upgrade
Quick Ratio
6.613.422.772.2513.1415.04
Upgrade
Current Ratio
7.003.612.972.5415.6617.42
Upgrade
Return on Equity (ROE)
-12.78%9.96%1.07%-2.87%-2.01%
Upgrade
Return on Assets (ROA)
-8.12%6.05%0.46%-1.74%-1.34%
Upgrade
Return on Capital (ROIC)
-9.34%6.93%0.50%-1.76%-1.36%
Upgrade
Return on Capital Employed (ROCE)
17.50%14.30%10.60%0.80%-2.90%-2.20%
Upgrade
Earnings Yield
4.70%3.06%2.10%0.25%-1.28%-0.74%
Upgrade
FCF Yield
5.44%3.86%3.14%3.26%-0.70%-0.22%
Upgrade
Dividend Yield
1.47%1.36%0.95%---
Upgrade
Payout Ratio
31.21%31.12%----
Upgrade
Buyback Yield / Dilution
-0.05%-0.06%-0.08%---
Upgrade
Total Shareholder Return
1.41%1.30%0.86%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.